The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free circulating chromatin profiling for epigenomic characterization of mechanisms of response and resistance to sacituzumab govitecan in breast cancer.
 
Ana Garrido-Castro
Honoraria - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer
Research Funding - 4D Path (Inst); AstraZeneca (Inst); Biovica (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Foundation Medicine (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Precede Bio (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Merck; Novartis; Pfizer; Roche/Genentech
 
Aparna Gorthi
Employment - AstraZeneca; Precede Bio
Stock and Other Ownership Interests - Precede Bio; Tempus (I)
 
Se Eun Kim
No Relationships to Disclose
 
Anthony DIppolito
Employment - Precede Bio
Travel, Accommodations, Expenses - Precede Bio
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; GE Healthcare; Gilead Sciences; Guardant Health; Merck; Moderna Therapeutics; Novartis; Sanofi; Seagen; Stemline Therapeutics; Summit Therapeutics
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Yara Abdou
Honoraria - Cancer Expert Now; Clinical Care Options; Clinical Care Options; MJH Associates; WebMD/Medscape
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Haystack Oncology (Inst); Natera (Inst)
(OPTIONAL) Uncompensated Relationships - Exact Sciences
 
Amy Clark
Honoraria - Siemens
Consulting or Advisory Role - Novartis
Research Funding - Lilly (Inst); Novartis (Inst); Seagen (Inst)
 
Ruth Sacks
Stock and Other Ownership Interests - Quest Diagnostics
Honoraria - DDHO conference; GA ASCO; ONC LIVE
Research Funding - Gilead Sciences
 
Thomas O'Connor
No Relationships to Disclose
 
Natalie Sinclair
No Relationships to Disclose
 
K.M. Steve Lo
No Relationships to Disclose
 
Jennifer Desrosiers
No Relationships to Disclose
 
Nancy Lin
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Eisai; Johnson & Johnson/Janssen; Menarini; Olema Pharmaceuticals; Pfizer; Seagen
Research Funding - Genentech (Inst); Merck (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett
Travel, Accommodations, Expenses - AstraZeneca; Olema Pharmaceuticals
 
Harold Burstein
No Relationships to Disclose
 
Elizabeth Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Alight Sciences; AstraZeneca; AstraZeneca; BioNTech SE; Merck; Merck; Moderna Therapeutics
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharpe and Dohme
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Roche/Genentech
 
Corrie Painter
Employment - Precede Bio
Stock and Other Ownership Interests - Precede Bio
 
Matthew Eaton
Employment - Precede Bio; Profluent Bio (I)
Leadership - Profluent Bio (I)
Stock and Other Ownership Interests - Precede Bio; Profluent Bio (I); Syros Pharmaceuticals; Tome Biosciences (I); Vor Biopharma (I)
Consulting or Advisory Role - Profluent Bio (I)
 
J. Barrett
Employment - AstraZeneca; Precede Bio
Leadership - Board of Directors SAGA Diagnostics
Stock and Other Ownership Interests - AstraZeneca; Corsita; Nexosomes; Precede Bio
Consulting or Advisory Role - Agilent; Akoya Biosciences; Bain Capital; Exai Bio; Leica Biosystems; MultiplexDX
 
Nabihah Tayob
No Relationships to Disclose
 
Sara Tolaney
Consulting or Advisory Role - AADi; Ambrx; Artios Biopharmaceuticals; Arvinas; AstraZeneca; Bayer; BeiGene; Bicycle Therapeutics; BioNTech; Blueprint Medicines; Bristol-Myers Squibb; Circle Pharma; Cullinan Oncology; Daiichi Sankyo; eFFECTOR Therapeutics; Eisai; Genentech; Hengrui Pharmaceutical (USA); Immunomedics/Gilead; Incyte; Jazz Pharmaceuticals; Johnson & Johnson; Launch Therapeutics; Lilly; Menarini Group; Merck; Mersana; Natera; Novartis; Pfizer; Reveal Genomics; Sanofi; Seagen; Sumitovant Biopharma; Summit Therapeutics; Systimmune; Tango Therapeutics; Zentalis; Zuellig Pharma; Zymeworks
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo; Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Menarini/Stemlin (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Arvinas; Gilead Sciences; Jazz Pharmaceuticals; Lilly; Pfizer; Sanofi
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Gilead Sciences